Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By China in Africa: The Real Story
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Chinese Loans to Africa: The Economist Gets it Wrong

% of readers think this story is Fact. Add your two cents.


On September 7th The Economist published an article, “China in Africa: Beyond Belt and Road,” with a graph on “murky” Chinese lending into Africa that really muddied the water (Figure A).

Figure A

The graph suggests that Chinese annual loan commitments to Africa peaked at close to $80 billion around 2017, using data from AidData. This compared with a peak of around $30 billion using data from Boston University and a peak of $14 bn around 2011 for the World Bank’s International Debt Statistics (IDS). 

The Economist implied that Boston University and the World Bank were underestimating China’s lending commitments in Africa because they were not shining their light in all the dark corners: specifically, they were not including all Chinese creditors and all kinds of loans. But instead, it appears to be The Economist that needs a better flashlight. 

As Chinese-loan-data-geeks, my Cornell University colleague Yufan Huang and I are very familiar with the World Bank’s IDS, AidData, and (of course) Boston University. We spent a good part of Sunday and Monday trying to replicate the numbers in The Economist’s chart. 

Here’s what we found. 

  • We guessed from the shape of the World Bank data curve that The Economist was only selecting “official” Chinese creditors, and not “private”. Yet many African countries (like Angola) report China Development Bank loans to the World Bank as “private”. [That data is in the IDS, but analysts need to select "official" and "private".] 
  • Working on that hunch, we were able to replicate the curve of the World Bank’s data using “official”, but not the amounts (Figure B). 
Figure B
  • What the Economists’ graph shows as $20 bn, should actually be labeled $10 bn. The data labels on the right axis are off by 100% for the World Bank data but, strangely, this is not the case for the Boston University data
  • When we added “private” Chinese loan commitments to the World Bank data (Figure C), we were able to bring the curve much closer to the Boston University curve. [Boston University includes all Chinese creditors, official and "private", that make loan commitments to African governments and their state-owned companies.] 
  • But the big problem came when we tried to replicate the AidData figures. 
  • BU, World Bank, and AidData have a few minor methodological differences.* But as Figures B & C show, the data from all three is actually quite similar** once we tried to replicate, correctly, what The Economist said it was trying to show in its graph. 
Figure C 
It’s been 13 years since I last suggested that The Economist badly needed to improve its reporting on China and Africa. They’ve gotten much better — but clearly there’s still work to be done. 
Chinese loans to Africa are not so murky — the World Bank, Boston University, and AidData all seem to agree on this. So what actually happened when The Economist crunched the numbers behind their graph? We’re eager to find out.
*Methodology Differences

A. Syndicated Loans. Boston University follows the World Bank’s International Debt Statistics reporting protocol. The World Bank asks countries to report syndicated loans, record the lead bank, and report “whether the syndicate comprises institutions of only one or of several countries.” If Chinese banks are part of an international syndicate with other multinational banks, this does not show up as a Chinese loan in either source. AidData does include these loans. Their methodology “assumes that each bank provided equal contributions to the syndicated loan” and they include the Chinese portion in their data.

B. Swap Lines. Boston University does not includes People’s Bank of China central bank swap lines in their development finance data, although they have a separate database on swaps. The World Bank only began requiring countries to report swap lines of greater than one year duration in 2020, so their data wouldn’t include most of these. AidData includes swaps, but in their most recent database, they record only about $4 bn in PBOC swap lines in Africa, covering only Nigeria and Egypt (in a separate swap database they also records PBOC swaps in Morocco and South Africa). 
C. Lines of Credit. The World Bank records Chinese lines of credit as a commitment in the year it happens. Boston University and AidData record instead the individual projects under those lines of credit. This explains why in Figures B & C, the World Bank data for 2011 spikes up and falls back, compared with BU and AidData.
D. Loans to Private Borrowers. Neither the World Bank nor Boston University report data on Chinese loans to private Chinese or other private sector borrowers in Africa, unless that loan has a public guarantee. AidData does include these private sector loans, coding them as either “potential public sector liability” (total of $6.8 bn) or purely private (total of $26 bn). Yet while this explains the difference between AidData and Boston University/World Bank in our Figures B & C, it doesn’t explain The Economist’s graph. 
**Sam Pa, China International Fund, and Angola
We wondered why the World Bank had a big bump of close to $20 bn ($10 bn once the data label is corrected) in Chinese loan commitments for 2005, when neither CARI/Boston University nor AidData had this figure. Digging into the World Bank data revealed that they had included $9.8 billion in “Chinese official loan commitments” for Angola — the exact amount that was allegedly pledged by the notorious Hong Kong company China International Fund (CIF). This private company, which later moved its headquarters to Singapore, failed in its boast that it would arrange that financing. (Their leader, Sam Pa, was arrested in 2015 under Xi Jinping’s anti-corruption campaign and hasn’t been heard from since). Despite its deliberately confusing name, CIF was a private Hong Kong company, not a Chinese official creditor, so it is included in error. 


Source: http://www.chinaafricarealstory.com/2024/09/chinese-loans-to-africa-economist-gets.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.